Press Releases
-
Phastar Vice President Prof Jennifer Visser-Rogers Named in Women in Data® Twenty in Data & Technology
Phastar Vice President Prof Jennifer Visser-Rogers Named in Women in Data® Twenty in Data & Technology Prof Visser-Rogers chosen for showcase of inspirational, trailblazing and dedicated women in data and tech.
Mar 6, 2024
-
Hovione partners with Dragonfly Technologies to offer micellar chemistry technology to customers as a sustainable alternative to conventional chemical processes
-
CD BioSciences Unveiled WMicroTrackers, Powered by Non-invasive Tracking Technology
-
Cresset Increases Its North America Presence with New Boston Site
Drug discovery specialists Cresset have announced the latest phase of their international expansion with the launch of a new facility in Boston to cement their existing commercial presence in North America
Mar 5, 2024
-
Greenphire Adds Industry Veteran Dan Shannon as New Chief Experience Officer
Dan Shannon joins Greenphire as Chief Experience Officer.
Mar 3, 2024
-
CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award
CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award 2024 Annual Association of Clinical Data Management (ACDM24) recognizes CluePoints’ improved methodology to proactively identify and address data quality.
Mar 4, 2024
-
Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials
Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials
Mar 4, 2024
-
WCG Expands New Statistical Consulting Solutions to Address Industry Resource Challenges
WCG’s Statistical Consulting Solutions empower biotechnology firms, CROs, pharmaceutical companies, medical device manufacturers, government agencies, and non-profit organizations with comprehensive statistical support across all stages of clinical trial design and regulatory strategy.
Mar 3, 2024
-
Synexa Life Sciences Expands Biomarker Discovery Capabilities with the Addition of Olink® Target Platform
Synexa Life Sciences has announced the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive suite of biomarker discovery platforms.
Mar 3, 2024
-
Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics
-
Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services
-
Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics
-
Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics
-
Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services
-
Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics
-
Principal IRB Becomes Univo IRB With Support From QHP Capital
Univo IRB was announced as the new company name for Principal IRB.
Feb 26, 2024
-
PathAI Launches New Pathologist-Centric Features on AISight to Enable Efficient Case Review through Intelligent Case Prioritization and Real-Time Multi-Institutional Collaboration
PathAI, Inc., a leading AI-powered precision pathology company, today announced the availability of two new features on the AISight digital pathology image management system – an Intelligent Caselist and AISight Live.
Feb 26, 2024
-
Creative Enzymes Rolls out Customized Solutions in Enzyme, Probiotic and Extract Blends
-
Creative Enzymes Proudly Unveils Its Cutting-Edge Product, Recombinant Human Hyaluronidase PH20
-
UNIVERSITY OF EDINBURGH ACKNOWLEDGES PELAGO PATENT AND USE OF CETSA® PROCESS
Pelago Biosciences has announced that the University of Edinburgh has acknowledged its Cellular Thermal Shift Assay (CETSA®) patent and use thereof in selected works in drug discovery research.
Feb 26, 2024